Trial Status:
Open to Enrollment
Trial Eligibility:
- Men and women 18 years or older with a diagnosis of ischemic stroke
- The stroke must be classified as "cryptogenic" or with no known cause
- Ability to participate in MRI scans
- Cannot be pregnant or breastfeeding
- Detailed eligibility will be reviewed when you contact the study team.
Trial Description:
The study is investigating a link between high-risk plaque and cardioembolic sources among patients with stroke of unknown causes. This observational study uses an MRI protocol to detect bleeds within plaque, a marker of high-risk plaque. There is an additional PET/MRI that patients can opt into to more closely observe the plaque within the carotid arteries.
This study includes optional parts which will have financial compensation.
Primary Investigator:
Hooman Kamel, MD
Trial Location:
Upper East Side - Manhattan
Drugs / Device:
na
Protocol ID:
1904020152
Study Type:
Observational
Sponsor:
National Institutes of Health (NIH)
Trial Category:
Intracranial Hemorrhage Stroke